What does CUSIP 22663K107 represent in this 13F holders report?

CUSIP 22663K107 is the security identifier for CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock in Q4 2021?

114 institutional investors reported CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock for Q4 2021. Use the holders table for investor-level position and value details.

Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)

CUSIP: 22663K107

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock
Shares outstanding: 94,401,153
Total 13F shares: 44,273,322
Share change: +8,733,372
Total reported value: $1,256,550,441
Price per share: $28.41
Number of holders: 114
Value change: +$251,517,738
Number of buys: 83
Number of sells: 24

Quarterly Holders Quick Answers

What is CUSIP 22663K107?
CUSIP 22663K107 identifies CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 22663K107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	4.7%	4,426,434	$93,177,000	—	30 Sep 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	4.2%	3,963,517	$83,432,000	—	30 Sep 2021	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	3.2%	2,998,512	$63,119,000	—	30 Sep 2021	13F
ORBIMED ADVISORS LLC	13F	Company	3.2%	2,996,876	$63,084,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	2.8%	2,616,839	$55,084,000	—	30 Sep 2021	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	1.8%	1,679,701	$35,358,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	1.8%	1,675,881	$35,277,000	—	30 Sep 2021	13F
5AM Venture Management, LLC	13F	Company	1.4%	1,362,286	$28,676,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	1.2%	1,115,859	$23,489,000	—	30 Sep 2021	13F
BVF INC/IL	13F	Company	1%	953,879	$20,079,000	—	30 Sep 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	0.98%	920,656	$19,380,000	—	30 Sep 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.97%	913,071	$19,220,000	—	30 Sep 2021	13F
FRAZIER MANAGEMENT LLC	13F	Company	0.9%	851,306	$17,920,000	—	30 Sep 2021	13F
Versant Venture Management, LLC	13F	Company	0.87%	820,720	$17,276,000	—	30 Sep 2021	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.58%	548,643	$11,549,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.55%	519,997	$10,945,000	—	30 Sep 2021	13F
Vivo Capital, LLC	13F	Company	0.55%	517,280	$10,889,000	—	30 Sep 2021	13F
Point72 Asset Management, L.P.	13F	Company	0.48%	449,800	$9,468,000	—	30 Sep 2021	13F
Opaleye Management Inc.	13F	Company	0.43%	402,113	$8,464,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.39%	366,999	$7,725,000	—	30 Sep 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.33%	311,344	$6,554,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.32%	302,345	$6,365,000	—	30 Sep 2021	13F
MPM BioImpact LLC	13F	Company	0.32%	298,392	$6,281,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.24%	223,247	$4,700,000	—	30 Sep 2021	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.21%	195,438	$4,114,000	—	30 Sep 2021	13F
Altium Capital Management LLC	13F	Company	0.2%	193,000	$4,063,000	—	30 Sep 2021	13F
Ghost Tree Capital, LLC	13F	Company	0.16%	150,000	$3,158,000	—	30 Sep 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.15%	146,292	$3,079,000	—	30 Sep 2021	13F
New Leaf Venture Partners, L.L.C.	13F	Company	0.15%	141,000	$2,968,000	—	30 Sep 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.15%	139,800	$2,943,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.13%	121,056	$2,760,000	—	30 Sep 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.1%	90,056	$1,896,000	—	30 Sep 2021	13F
Russell Investments Group, Ltd.	13F	Company	0.09%	83,104	$1,748,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.07%	68,954	$1,451,000	—	30 Sep 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.07%	66,163	$1,393,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.06%	55,425	$1,167,000	—	30 Sep 2021	13F
Swiss National Bank	13F	Company	0.05%	49,600	$1,044,000	—	30 Sep 2021	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.05%	49,382	$1,039,000	—	30 Sep 2021	13F
ALPS ADVISORS INC	13F	Company	0.05%	47,436	$999,000	—	30 Sep 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.04%	42,095	$886,000	—	30 Sep 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.04%	38,650	$814,000	—	30 Sep 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.04%	38,600	$813,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.04%	37,219	$783,000	—	30 Sep 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	35,403	$745,000	—	30 Sep 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	29,500	$621,000	—	30 Sep 2021	13F
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY	13F	Company	0.03%	27,597	$581,000	—	30 Sep 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.03%	27,513	$579,000	—	30 Sep 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.03%	26,387	$555,000	—	30 Sep 2021	13F
Blackstone Inc.	13F	Company	0.03%	24,334	$512,000	—	30 Sep 2021	13F
CITIGROUP INC	13F	Company	0.03%	23,763	$500,000	—	30 Sep 2021	13F

Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q4 2021

As of 31 Dec 2021, Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,273,322 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, FMR LLC, BlackRock Inc., ORBIMED ADVISORS LLC, BVF INC/IL, VANGUARD GROUP INC, Bain Capital Life Sciences Investors, LLC, Deep Track Capital, LP, and FRAZIER MANAGEMENT LLC. This page lists 114 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

114

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.